IR Biosciences Holdings Inc.
IR Biosciences Holdings Inc. (IRBS) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · IRBS · as of Jun 9, 2026
Key Statistics
Explore IR Biosciences Holdings Inc. Data
irbs stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
irbs competitorsIRBS
AMPE
BIOAF
EHOS
GBLX
GSTCStock Performance
Full HistoryAbout IR Biosciences Holdings Inc.
IR Biosciences Holdings Inc. IR BioSciences Holdings, Inc. is a U.S.-based, early-stage biotechnology firm. Through its subsidiary, ImmuneRegen BioSciences, Inc., it concentrates on researching and developing therapies for signif…
what is ir biosciences holdings inc. · irbs stock overview · ir biosciences holdings inc. company profile · who is ir biosciences holdings inc. ceo · irbs OTC · ir biosciences holdings inc. headquarters · ir biosciences holdings inc. business segments
About Stock Overview & Key Data
IR Biosciences Holdings Inc. (IRBS) is a Healthcare company in the Biotechnology industry, listed on OTC since Jun 27, 2023. As of the latest trading session, IRBS stock price is $0.00, with a market capitalization of $128,122. The stock has returned +0.00% over the past 12 months and +0.00% year-to-date.
In fiscal year 2010, IR Biosciences Holdings Inc. reported revenue of —. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, IR Biosciences Holdings Inc. (IRBS) stock price is $0.00. The stock is traded on OTC under the ticker symbol IRBS. The 52-week range is $0.00 – $0.00.